头孢噻唑丁酸(ceftazidime)是一种新型头孢菌素,它对多种革兰氏阴性杆菌,包括绿脓杆菌、吲哚阳性变形杆菌有高度抗菌作用,但对金黄包葡萄球菌作用较其他头孢菌素弱。肾功能正常者,头孢噻唑丁酸的半衰期为1.9h。静脉给药1g,药在脓、痰、胆汁达到治疗浓度。药在体内不代谢,约90%以原型从尿排出,可静注或肌注给药。 Ceftazidime is a novel cephalosporin that is highly antibacterial against a wide range of Gram-negative bacilli, including Pseudomonas aeruginosa, and Indole-positive Proteobacteria, but has a greater antibacterial effect against Staphylococcus aureus than other cephalosporins Mycotoxin weak. Normal renal function, ceftizoxazole half-life of 1.9h. Intravenous administration 1g, medicine in pus, sputum, bile to the treatment concentration. Drugs are not metabolized in the body, about 90% of the prototype discharged from the urine, intravenous or intramuscular administration.